About ICON plc
ICON plc is a global provider of consulting, development, and commercialisation services for the development of drugs and devices. The work is broad. The company works to help clients accelerate programs that aim to save lives and improve quality of life, and it keeps its focus on delivering information, solutions, and performance across the development process.
Founded in Dublin, Ireland in 1990, ICON operates through a global network of offices in 53 countries and employs more than 10,000 people. Its teams have experience across a broad range of therapeutic areas, and they support clients with services intended to reduce time to market, reduce cost, and improve quality.
Need to reach the ICON plc team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026ICON plc operates in the medical research and clinical development services market. A recent filing showed that Wellington Management Group LLP cut its stake by 10.0% in the second quarter after selling 592,983 shares. Even so, the position was still large at 5,320,054 shares.
Context is limited. The only supplied source identifies ICON plc as a medical research company, but it does not give peer data, pricing detail, wins, or market share, so there is no basis here for a wider competitive read-through. The filing also says nothing about management priorities, hiring, guidance, or product changes.
Investor sentiment looks mixed to cautious. That view comes mainly from the stake reduction disclosed by Wellington Management Group LLP. No earnings, funding, or operating updates were included in the material, so there is not enough evidence to judge near-term business momentum beyond that ownership change.
Frequently asked questions
ICON plc is headquartered in Dublin, Dublin, Ireland.
ICON plc has 10001+ employees according to its company profile.
ICON plc operates in the Biotechnology sector. Public valuation figures are not always disclosed for private companies.